CLINICAL_TRIALS
withdrawal
· 2016-05-17
Clinical Trial Update: More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery [Phase 2]
Summary
A Phase 2 trial investigating fluorescence-guided surgery for removing malignant brain tumors has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Constantinos Hadjipanayis | Conditions: Benign Neoplasms, Brain, Brain Cancer | Phase 2 | Status: WITHDRAWN